<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854659/" ref="ordinalpos=1018&amp;ncbi_uid=5680965&amp;link_uid=PMC3854659" image-link="/pmc/articles/PMC3854659/figure/F1/" class="imagepopup">Fig. (1).  From: Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery. </a></div><br /><div class="p4l_captionBody">Both G-protein and β-arrestin mediated signaling pathways can lead to ERK activation. However, the subcellular distributions of activated ERK1/2 are different. The phosphorylated ERK1/2 mediated by the β-arrestin signaling pathway largely remain in cytoplasm, while the phosphorylated ERK1/2 mediated by the G-protein signaling pathway translocate to the nucleus.</div></div>